BHWM
SGMO

Beaird Harris Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Beaird Harris Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-87
Closed – – 769
2022
Q3 		$0 Hold
87
– – ﹤0.01% 526
2022
Q2 		$0 Hold
87
– – ﹤0.01% 571
2022
Q1 		$1K Hold
87
– – ﹤0.01% 578
2021
Q4 		$1K Buy
+87
New +$756 ﹤0.01% 619

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Beaird Harris Wealth Management's SGMO Position: Q4 2022 in Review

Beaird Harris Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 87 shares.

Beaird Harris Wealth Management first reported a position in SGMO in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Beaird Harris Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 87 SANGAMO THERAPEUTICS INC shares in Q4 2022.
  • Beaird Harris Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 4 quarters.
  • Beaird Harris Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $1K in Q1 2022.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.